Stem Cells International

Stem Cells International / 2017 / Article
Special Issue

The Stem Cell Niche: Interactions between Stem Cells and Their Environment

View this Special Issue

Research Article | Open Access

Volume 2017 |Article ID 9841035 |

Andrea da Fonseca Ferreira, Pricila da Silva Cunha, Virgínia Mendes Carregal, Priscila de Cássia da Silva, Marcelo Coutinho de Miranda, Marianna Kunrath-Lima, Mariane Izabella Abreu de Melo, Camila Cristina Fraga Faraco, Joana Lobato Barbosa, Frédéric Frezard, Vivian Resende, Michele Angela Rodrigues, Alfredo Miranda de Goes, Dawidson Assis Gomes, "Extracellular Vesicles from Adipose-Derived Mesenchymal Stem/Stromal Cells Accelerate Migration and Activate AKT Pathway in Human Keratinocytes and Fibroblasts Independently of miR-205 Activity", Stem Cells International, vol. 2017, Article ID 9841035, 14 pages, 2017.

Extracellular Vesicles from Adipose-Derived Mesenchymal Stem/Stromal Cells Accelerate Migration and Activate AKT Pathway in Human Keratinocytes and Fibroblasts Independently of miR-205 Activity

Academic Editor: Sari Pennings
Received03 Mar 2017
Revised27 Jul 2017
Accepted23 Aug 2017
Published05 Nov 2017


Mesenchymal stem/stromal cells (MSCs) are promising tools in cell therapy. They secrete extracellular vesicles (EVs) that carry different classes of molecules that can promote skin repair, but the mechanisms are poorly understood. Skin wound healing is a complex process that requires the activity of several signaling pathways and cell types, including keratinocytes and fibroblasts. In this study, we explored whether adipose tissue MSC-derived EVs could accelerate migration and proliferation of keratinocytes and fibroblasts, activate the AKT pathway, and promote wound healing in vivo. Furthermore, we evaluated if EV effects are miR-205 dependent. We found that MSC EVs had an average diameter of 135 nm. Keratinocytes and fibroblasts exposed to EVs exhibited higher levels of proliferation, migration, and AKT activation. Topical administration of EVs accelerated skin wound closure. Knockdown of miR-205 decreased AKT phosphorylation in fibroblasts and keratinocytes, whereas migration was decreased only in keratinocytes. Moreover, knockdown of miR-205 failed to inhibit AKT phosphorylation in fibroblasts and keratinocytes exposed to EVs. About the mechanism of EV effects, we found that incubation with EVs prevented inhibition of AKT activation by miR-205 knockdown, suggesting that EVs activate AKT independently of miR-205. In conclusion, we demonstrated that EVs are a promising tool for wound healing.

1. Introduction

Mesenchymal stem/stromal cells (MSCs) can be isolated from many adult tissues [1]. Human adipose tissue was chosen as the source of stem cells in this study, due to its easy access and high mesenchymal stem cell population. The extraordinary plasticity of these cells was originally thought to contribute to their well-established therapeutic efficacy in a wide variety of disease models, as well as in human clinical trials. However, recent findings suggested that MSCs have a remarkable influence on the microenvironment by secreting a wide range of bioactive factors. This ability may contribute more to tissue repair than to their capacity for transdifferentiation [2].

MSC secretome comprises a wide variety of biomolecules, including cytokines, growth factors, and RNAs. These molecules could modulate the microenvironment and, thus, be responsible for the majority of beneficial effects of stem cells in tissue repair [3]. Recent studies indicated that MSCs also secrete extracellular vesicles (EVs) that contribute to cell-cell communication. After internalization, EVs may alter recipient cell fate by delivering transcriptional factors able to modulate cellular properties [4, 5].

On the other hand, wound repair is a complex process controlled by many secreted factors, including soluble proteins and RNAs [6]. Many preclinical and clinical studies have demonstrated that administration of MSCs accelerates wound closure, reduces scarring, and promotes collagen synthesis and angiogenesis [7, 8]. However, the mechanisms and factors responsible for the improvement of wound healing process during stem cell therapy are still poorly understood.

Several biochemical pathways coordinate skin integrity restoration [9]. The pathway regulated by miR-205 is involved in cell migration and proliferation. Lack of miR-205 results in epidermal defects caused by impaired proliferation, whereas genetic deletion of miR-205 leads to neonatal mortality in mice [10]. This microRNA modulates AKT activation and, therefore, increases migration in epithelial cells and promotes wound healing [11].

In this study, we evaluated the ability of adipose-derived MSC EVs to increase cell proliferation, migration, and AKT activation in human keratinocytes and fibroblasts and to promote wound healing in vivo. Furthermore, we examined whether EV effects on migration and activation of AKT were dependent on miR-205. Here, we demonstrated that EVs and its molecules are promising tools for wound healing.

2. Materials and Methods

2.1. MSC Isolation and Culture

MSCs were isolated from subcutaneous adipose tissue donated freely by lipoplasty surgery patients according to the regulations approved by the Universidade Federal de Minas Gerais’s Research Ethics Committee (348/2016). Cell extraction was carried out as described by Zuk et al. [12]. Briefly, tissue samples were washed twice with phosphate-buffered saline (PBS, pH 7.4; Thermo Fisher Scientific, Waltham, MA, USA) to remove blood cells and incubated with 0.1% collagenase solution (Thermo Fisher Scientific) for 45 min at 37°C. After incubation, samples were centrifuged at 300 ×g for 7 min, the supernatant was discarded, and the remaining pellet was resuspended in Dulbecco’s modified Eagle’s medium (DMEM; cat. number: 12800-017, Thermo Fisher Scientific) containing 10% fetal bovine serum (FBS; Thermo Fisher Scientific) and 1% penicillin/streptomycin (PS; Sigma-Aldrich, St. Louis, MO, USA). Cells were transferred to culture flasks and kept in a humidified atmosphere of 95% air and 5% CO2 at 37°C. Culture medium was changed every 3 days.

2.2. Characterization of MSCs by Cytometry

MSCs (106 cells per sample) were incubated with 0.4 μg of primary antibodies against CD73 (Thermo Fisher Scientific, cat. number: 41-0200), CD90 (Thermo Fisher Scientific, cat. number: 14-0909-82), CD105 (Thermo Fisher Scientific, cat. number: 12-105742) (traditional membrane stem cell markers), CD19 (Thermo Fisher Scientific, cat. number: 11-0199-42), and CD45 (Thermo Fisher Scientific, cat. number: 11-9459-42) (hematopoietic cell markers) for 30 min at 4°C [13]. After washing, cells were incubated with a secondary antibody for 30 min at 4°C, washed again, and suspended in PBS. Alexa Fluor 488 goat anti-mouse (Thermo Fisher Scientific) was used for unconjugated primary antibodies. In control experiments, cells were incubated only with the secondary antibody to exclude nonspecific binding. Cytometry was performed using a Guava® EasyCyte™ 6–2 L (Millipore, Temecula, CA, USA). For each sample, at least 5000 events were acquired. Results were analyzed with FlowJo 7.6.5 software (LLC, Ashland, OR, USA).

2.3. Differentiation of Chondrocytes, Adipocytes, and Osteocytes

MSCs were incubated for 21 days in specific differentiation media, as previously described [12]. Following incubation, cells were fixed and stained by Von Kossa, oil red O, and alcian blue stains to visualize osteogenic, adipogenic, and chondrogenic differentiation, respectively. Although other strategies could be used to verify osteogenic and chondrogenic differentiation, Von Kossa and alcian blue stains are still regarded as good methods for that purpose. Next, cells were imaged using a QIClick camera (QImaging, Surrey, BC, Canada) coupled to an IX70 Olympus microscope controlled by Image-Pro Plus 7.0.1 (Media Cybernetics, Rockville, MD, USA).

2.4. EV Isolation

EVs were isolated as previously described [14]. Briefly, stem cells were incubated with serum-free DMEM for 48 h at 37°C, in the atmosphere of 95% air and 5% CO2. This step was necessary to assure that the medium collected had only EVs from stem cells, as serum-free DMEM does not contain EVs. After the incubation period, the medium underwent successive centrifugation steps. The first centrifugation was at 300 ×g for 7 min; then, the supernatant was centrifuged for 15 min at 1000 ×g, followed by another supernatant centrifugation for 40 min at 10000 ×g. Then, the supernatant was ultracentrifuged (100000 ×g for 70 min). Finally, the supernatant underwent the last ultracentrifugation (100000 ×g for 70 min), and the resulting pellet was composed of EVs. All centrifugation steps were carried out at 4°C. Cells used for EV extraction were in the fourth or fifth passage. For every complete experiment, EVs from stem cells from three different patients were isolated and used, totalizing 45 samples from 48 different patients in this study.

2.5. EV Characterization and Concentration

EVs isolated from serum-free DMEM as described above were resuspended in PBS and analyzed using NanoSight LM 10 system and Nanoparticle Tracking Analysis software (Malvern Instruments Ltd., Malvern, UK). We used 1.9 × 108 vesicles in each experiment.

2.6. Isolation and Culture of Human Keratinocytes and Fibroblasts

Human keratinocytes were extracted as described by Zonari et al. [8]. Human skin samples were donated with consent from the patients that underwent abdominoplasty surgery according to regulations specified by the Universidade Federal de Minas Gerais Research Ethics Committee (55698116.2.0000.5149). The skin was separated from adipose subcutaneous tissue with scissors, and the fatty tissue was discarded. Then, skin samples were fragmented into 5 mm2 pieces and incubated in dispase solution (2.5 UI) for 16 h at 4°C. After this, the dermis and epidermis were separated with tweezers (fibroblasts were extracted from the dermis and keratinocytes—from the epidermis). The dermis was incubated in a 0.1% collagenase solution (Thermo Fisher Scientific) for 3 h at 37°C, and the epidermal fragments were incubated with 0.05% trypsin solution for 5 min at 37°C. After the incubation period, a cell scraper was used to remove the fragments of the epidermis to release keratinocytes. The resulting material was then passed through a 100 μm filter to only collect the cells that were then placed in culture flasks with keratinocyte serum-free medium (KSFM) and cultured at 37°C in the atmosphere of 95% air and 5% CO2. After a 3 h incubation in collagenase solution, dermal fragments that remained undigested were discarded, and the supernatant underwent centrifugation for 7 min at 300 ×g. The resulting pellet was resuspended in DMEM containing 10% FBS and 1% PS and transferred to a culture flask. Cells were kept in a humidified atmosphere of 95% air and 5% CO2 at 37°C, and the medium was changed every three days.

2.7. Growth Curves

The growth curves were performed in keratinocytes and fibroblasts seeded in 24-well plates (5 × 104 cells per well) and exposed to the medium with or without MSC EVs. The concentration of vesicles used was 3.16 × 107 per mL and each well was exposed to one mL of enriched medium. Cells were counted in a Neubauer chamber daily for eight consecutive days. Cell counts were used to plot a growth curve.

2.8. Western Blot

For experiments with EVs, cells were exposed to enriched medium and the concentration of vesicles used were 3.16 × 107 per mL. Initially, total protein samples were isolated from cells exposed to EVs using a sterile cell scraper and a lysis buffer (150 mM NaCl, 1 mM EDTA, 20 mM Tris–HCl, pH 8.0, 0.5% Nonidet P-40). Total protein concentration was quantified by the Bradford method (Bradford, 1973), and then, samples underwent electrophoresis. Proteins were then transferred to polyvinylidene fluoride membranes using a Trans-Blot® SD semidry transfer cell (BioRad, Hercules, CA, USA). Immunoblotting was performed by standard methods, as previously described [15]. Primary antibodies against total AKT (Cell Signaling Technology, Danvers, MA, USA; cat. number 9272, 1 : 1000), phospho-AKT (Cell Signaling Technology; cat. number 4060, 1 : 500), phospho-histone 3 (Sigma-Aldrich; cat. number MFCD01633984, 1 : 500), total histone H3 (Sigma-Aldrich; cat number MFCD01322157, 1 : 2000), Alix (Cell Signaling Technologies, cat. number: 2171), and CD9 (cat. number: MA1 80-307) were used. Band density analysis was performed using ImageJ software (

2.9. Scratch Wound Healing Assay

Human keratinocytes and dermal fibroblasts were seeded in 6-well plates at 80% confluence. After exposure to KSFM or DMEM (depending on the cell type) for 48 h, a scratch was made on the cell monolayer with a sterile 200 μL pipette tip. Wells were washed with PBS and then exposed to MSC EVs. The concentration of vesicles used were 3.16 × 107 per mL in each well. Scratch closure was monitored by imaging at 0, 12, and 24 h. Scratch areas were measured by Image-Pro Plus Software.

2.10. Excisional Wound-Splinting Model

All animal experiments were performed after obtaining an approval from the University Research Ethics Committee (168/2013). The excisional wound-splinting model was used as described by Wang and colleagues [16]. This model facilitates the approximation between rat and human skin wound healing by reducing skin traction. Briefly, 24 male Wistar rats (220 g) were divided into two groups: test group and negative control group. Animal groups were further divided into three subgroups of four animals, for assessments at 7, 14, and 21 days after exposure to gel preparations. Rats were anesthetized using an intraperitoneal injection of ketamine and xylazine. Excision wounds (5 mm in diameter) were made on rat dorsal skin with a mini punch. Sterile silicone rings were glued around the wounds with a high-performance glue. Animals were placed in individual cages and received aspirin for pain relief. Throughout the experiment, they had free access to food and water.

2.11. Gel with EVs

Hydroxyethyl cellulose aqueous gel (2%) was made in sterile conditions and admixed to EV suspension (1.9 × 108 vesicles) in a 1 : 1 ratio. The resulting 1% hydroxyethyl cellulose gel comprising MSC-derived EVs was aseptically applied daily on wounds of animals in the test group, whereas animals from the control group were treated with plain 1% hydroxyethyl cellulose gel without EVs. Wound parameters were assessed at 7, 14, and 21 days after the wound was made. Images were taken every day.

2.12. Real-Time PCR

Human keratinocytes and dermal fibroblasts were seeded in 6-well plates (5 × 105 cells per well). RNA was extracted with a mirVana® RNA extraction kit (Thermo Fisher Scientific) and used for reverse transcriptase reaction. We used a TaqMan probe kit (Thermo Fisher Scientific, cat. number 4427975); amounts of RNA and cDNA were as recommended by the manufacturer. The reactions were read using a 7900HT Fast Real-Time PCR System and analyzed with SDS 2.4 software (Thermo Fisher Scientific). Relative gene expression was calculated by the 2−(ΔΔCt) method [17].

2.13. Transfection of siRNA

Transfection was conducted as recommended by the manufacturer. Human dermal fibroblasts and keratinocytes were seeded at 60–70% confluence and then exposed to a suspension of Lipofectamine 2000 (Thermo Fisher Scientific) with 25 nM siRNA in Opti-MEM (Thermo Fisher Scientific) for 5 h. The siRNAs used were all purchased from Thermo Fisher Scientific: mirVana miRNA inhibitor, hsa-miR-205-5p (assay ID: MH11015; catalog number: 4464084); mirVana miRNA mimic, hsa-miR-205-5p (assay ID: MC11015, catalog number: 4464066); and mirVana miRNA inhibitor negative control number 1 (catalog number: 4464076). After the incubation, the transfection medium was discarded and replaced by DMEM or KSFM, depending on the cell type. Tests were performed after 48 h.

2.14. Statistical Analysis

The data shown represent at least three independent experiments and are expressed as the mean ± standard deviation. The statistical analyses were performed with GraphPad software. The experiments with more than two data groups were compared by using one-way ANOVA and the Bonferroni posttest. values of at least <0.05 were considered to be statistically significant.

3. Results and Discussion

3.1. Characterization of MSCs

Initially, MSCs were characterized according to the three criteria proposed by the Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy [18]. First, cell-surface antigen profile was ascertained by staining the cells with specific monoclonal antibodies, followed by cytometry analyses (Figure 1). We investigated the expression levels of cell markers CD90 (91.4% ± 0.1%), CD73 (92.9% ± 0.1%), CD105 (92% ± 0.1%), CD19 (4.9% ± 0.1%), and CD45 (1.3% ± 0.1%). These percentages of labeled cells indicated acceptable culture purity according to the criteria proposed by Bourin et al. [18]. MSCs adhered to the plastic material of the plates and showed fibroblast-like morphology (polygon-like or spindle-like with processes, Figure 1(b)). Finally, MSCs were capable of differentiating into adipocytes, osteoblasts, and chondrocytes (Figure 1(b)). After 21 days of exposure to differentiation medium followed by oil red O, Von Kossa, or alcian blue staining, it was possible to observe differentiation of stem cells into different types of cells, which displayed fat droplets in their cytoplasm, mineral deposits, and proteoglycan inclusions, respectively. These results suggested that the cell population isolated from subcutaneous adipose tissue in this study indeed comprised true MSCs, classified according to the criteria of the Tissue Stem Cell Committee of the International Society for Cellular Therapy [18].

3.2. Characterization of EVs Isolated from MSCs

Next, EVs were analyzed by a NanoSight LM 10 system, using Nanoparticle Tracking Analysis (NTA) software. Results of these experiments are shown in Table 1 and in Figure 2. The average diameter of the vesicles observed in our preparations was 135 nm. We also determined their density, spreading speed, and sample viscosity. As shown in Figure 2, the curve base is broad, indicating that there is variation in size within the population. Accumulating data support the notion that the content, size, and membrane composition of EVs are highly heterogeneous and dynamic, depending on the cellular source, state, and environmental conditions [19, 20]. Also, we performed Western blot for Alix and CD9, two proteins present in EVs. Many efforts have been made by the scientific community to isolate EV subtypes, but the results were inconclusive. Hence, in this work, we assumed that we dealt with a mixture of different EV populations [19].

CharacteristicSample data

Average size135 nm
Concentration1.89 × 108 particles/mL
Spreading speed1.201 nm·s−1
Sample viscosity0.90 cP

Data were generated by the Nanoparticle Tracking Analysis software.
3.3. EVs Increased Proliferation of Fibroblasts and Keratinocytes

To assess whether MSC EVs could induce proliferation of fibroblasts and keratinocytes in vitro, cells of both types were exposed to MSC EVs and two kinds of experiments were conducted. As shown in Figure 3(a), growth curves of fibroblasts and keratinocytes indicated that MSC EVs increased cell proliferation, which would be a beneficial factor for wound healing [9, 21]. Western blot analysis showed greater phosphorylation of histone H3, a mitosis marker [22], in cells of both types when exposed to MSC EVs (Figures 3(b) and 3(c)). Those results indicated that EVs modified epithelial cell proliferation. Previously, it has been reported that EVs from stem cells induced cell proliferation by modulating microenvironments and promoting mitosis [23, 24]. As cell proliferation is a key step in skin wound healing, and its impairment is directly associated with the formation of chronic wounds, the capacity of stem cell EVs to accelerate this process may be a useful therapeutic feature.

3.4. EVs Induced Migration of Fibroblasts and Keratinocytes

Epidermal keratinocytes and dermal fibroblasts were used in scratch wound healing assays, as described in Materials and Methods. As shown in Figure 4, the presence of EVs in the culture medium was associated with a more rapid decrease in the area affected by the initial wound, indicating increased migration after 24 h of exposure to MSC EVs in cells of both types. Cell migration in the wound bed is essential for skin wound healing, and it is known to be affected in some chronic conditions, for example, in diabetic chronic wounds [25]. It has been suggested that one of the reasons of skin cell migration impairment in chronic wounds is the depletion of stem cells in those areas, which creates imbalance in the microenvironment and decelerates wound healing process. It will be interesting to substantiate in more direct experiments whether MSC EVs and their signals can indeed modulate cell migration, as suggested by our results (Figure 4) and by data from other groups [23, 24].

3.5. EVs Accelerated Wound Healing

Male Wistar rats were subjected to the excisional wound-splinting procedure and then exposed to aqueous hydroxyethyl cellulose gel with or without MSC EVs for 7, 14, and 21 days. We found that treated animal wounds closed more rapidly than control wounds (Figure 5(a)). Furthermore, we observed that in rats treated with the gel enriched with MSC EVs, wound closure occurred at a faster rate than in animals treated with EV-free gel (Figure 5(b)). Acceleration of wound healing by stem cell-derived EVs has been reported previously. However, in those experiments, more invasive treatments, namely, intradermal injection of stem cell EV preparations were used [26]. In this work, we demonstrated comparable acceleration of wound healing by topical application of MSC EVs, which is a more advantageous setting that causes less therapeutic discomfort. Our results seem to be in accordance with suggestions of other authors about a promising potential of MSC EVs in skin wound healing [26, 27].

3.6. EVs Promoted AKT Phosphorylation in Fibroblasts and Keratinocytes

The AKT pathway is considered one of the major biochemical pathways regulating migration of epithelial cells. To assess whether MSC EVs induced AKT activation, Western blot assays were performed in fibroblasts and keratinocytes. As shown in Figure 6, exposure of keratinocytes and fibroblasts to MSC EVs was associated with higher levels of phosphorylated AKT, which would increase the overall activity of the AKT pathway. Sometimes, there are some double bands in the Western blots for total AKT. The heaviest band was used for quantifications that was the band always present in the phosphorylated form. Recently, other authors found that AKT phosphorylation was higher in skin cells exposed to MSC EVs [10, 11]. Those results are interesting from the therapeutic point of view, as modulation of the AKT pathway activity may be a promising avenue of research into novel stimulators of wound healing process.

3.7. Exposure of Fibroblasts and Keratinocytes to EVs Increased miR-205 Expression

It has been shown that one of the most abundant microRNAs in the skin, miR-205, is an important modulator of AKT pathway activity [11]. Moreover, we found the presence of miR-205 in EV samples from MSCs, through the Next Generation Sequencing experiments (data not shown). To evaluate whether MSC EVs modulated miR-205 expression, qPCR experiments were conducted in fibroblasts and keratinocytes after exposure to EVs for 24 h. We found that treatment with MSC EVs led to a ~3-fold increase in miR-205 expression level (Figure 7(a)). Although miR-205 is present inside the EVs from stem cells, we could not assume at this point that the increased expression observed in qPCR experiments is strictly due to the transfer from EVs to cells with the experiments described here. As widely known, microRNA biology is complex and could be modulated by several factors, including other microRNAs [10, 11].

Next, we carried out qPCR experiments to verify expected changes in cellular miR-205 levels after its overexpression or knockdown. Transfection of 25 nM of miR-205 sequence increased the expression level of this microRNA ~ 6-fold in both fibroblasts and keratinocytes (miR-205 mimic). We also examined the consequences of miR-205 knockdown in cells before (siRNA group) and after exposure to EVs (siRNA + EVs). We achieved 100% knockdown in both cell groups transfected with siRNA. Expression levels of miR-205 in cells exposed only to the transfection reagent lipofectamine (lipofectamine group) or lipofectamine plus a scramble sequence (scramble group) did not change, as expected (Figure 7(b)).

We also examined the effects of miR-205 overexpression and knockdown on AKT activation by performing Western blot analysis of the levels of phosphorylated and total AKT (Figure 7(c)). In human fibroblasts and keratinocytes, miR-205 overexpression did not induce significant AKT phosphorylation compared to the levels detected in cells treated with lipofectamine or scramble RNA. This result contrasted with the data reported by Yu et al. [11] who showed that miR-205 could induce AKT activation in keratinocytes. This could be attributed to the miR-205 concentration used. We decided not to increase the concentration of siRNA because we already had a 6-fold change in cells transfected with miR-205 mimic sequence that was around twice the amount of miR-205 found in the cells exposed to EVs. However, miR-205 knockdown led to lower levels of phosphorylated AKT in cells of both types, as previously demonstrated.

Properties of fibroblasts and keratinocytes exposed to MSC EVs were similar when miR-205 was silenced. They exhibited higher levels of AKT phosphorylation than cells treated with lipofectamine only. These results indicated that AKT activation upon exposure to MSC EVs was likely independent of miR-205 expression. Considering the complexity of EV cargo, it is known that other molecules present in the vesicles could work collectively, modulating the microenvironment, favoring migration in skin cells. We are currently analyzing others RNAs present to the EVs to further investigate other potential targets for wound healing process. Also, several growth factors could be present in the EVs. Perhaps many molecules could participate in the effects described in this paper.

Finally, we investigate the migration effects of miR-205 overexpression and knockdown in fibroblasts and keratinocytes (Figure 8). The migration of fibroblasts was not affected by miR-205 overexpression or knockdown, but knockdown cells exposed to EVs showed faster migration. This result suggests that the migration of fibroblasts was independent of miR-205 and that EVs could have other molecules responsible for increasing fibroblast migration. On the other hand, migration of keratinocytes was increased by miR-205 overexpression. Accordingly, the knockdown of miR-205 made migration of keratinocytes similar to the levels of control groups, but the knockdown cells exposed to EVs had an increased migration. Taken together, these results suggest that miR-205 is important for keratinocyte migration, but, for the migration effect induced by EVs, its expression seems not to be essential.

Many studies are showing a complex role of miR-205 in many models [28]. For example, In HaCaT keratinocytes, miR-205 knockdown could promote migration in scratch wound healing assay. This could be due to the different cells used or because of the complex network of miR-205 [29]. In cancer, it acts either as an oncogene through facilitating tumor proliferation and initiation or as a tumor suppressor by inhibiting invasion and proliferation [28].

Considering the complexity of EV cargo, it is known that other molecules are present such as several growth factors and mRNAs. Perhaps many molecules could participate in the effects described in this paper. It is important, then, to fully elucidate the content of those EVs in terms of mRNAs, microRNAs, proteins, and other classes of molecules as to further explain the effects observed in this work.

4. Conclusion

In summary, our data suggest that cell migration and proliferation, key processes in skin wound healing, can be enhanced by exposure to MSC-derived EVs, which activate the AKT pathway in a miR-205-independent manner. Topical administration of a gel containing MSC EVs accelerated wound healing in an animal model, and this is an interesting finding as it opens perspectives for noninvasive model studies. For further development of this approach, it will be interesting to determine EV cargo and the molecules and mechanisms that mediate beneficial effects of MSC-derived EVs observed in this study.

Conflicts of Interest

The authors declare that they have no competing interests.


This work was supported by the NIH grant 1R03TW008709 and by grants from the “INCT-Regenera,” “Rede Mineira de Engenharia de Tecidos e Terapia Celular (REMETTEC, RED-00570-16),” FAPEMIG, CAPES, and CNPq. The authors also thank “Pró-Reitoria de Pesquisa da Universidade Federal de Minas Gerais” for its financial sponsorship. The authors would like to thank Editage ( for English language editing and Carolina de Andrade for Western blot assistance.

Supplementary Materials

Supplementary figure 1 - Stem cell EVs induce tube formation in HUVEC cell line.

  1. Supplementary material


  1. A. Uccelli, L. Moretta, and V. Pistoia, “Mesenchymal stem cells in health and disease,” Nature Reviews Immunology, vol. 8, no. 9, pp. 726–736, 2008. View at: Publisher Site | Google Scholar
  2. D. G. Phinney and D. J. Prockop, “Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair — current views,” Stem Cells, vol. 25, no. 11, pp. 2896–2902, 2007. View at: Publisher Site | Google Scholar
  3. C. Tran and M. S. Damaser, “Stem cells as drug delivery methods: application of stem cell secretome for regeneration,” Advanced Drug Delivery Reviews, vol. 82, pp. 1–11, 2015. View at: Publisher Site | Google Scholar
  4. S. Bruno, M. C. Deregibus, and G. Camussi, “The secretome of mesenchymal stromal cells: role of extracellular vesicles in immunomodulation,” Immunology Letters, vol. 168, no. 2, pp. 154–158, 2015. View at: Publisher Site | Google Scholar
  5. B. György, T. G. Szabó, M. Pásztói et al., “Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles,” Cellular and Molecular Life Sciences, vol. 68, no. 16, pp. 2667–2688, 2011. View at: Publisher Site | Google Scholar
  6. T. S. Stappenbeck and H. Miyoshi, “The role of stromal stem cells in tissue,” Science, vol. 1666, no. 2009, pp. 1666–1670, 2010. View at: Publisher Site | Google Scholar
  7. Y. Wu, L. Chen, P. G. Scott, and E. E. Tredget, “Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis,” Stem Cells, vol. 25, no. 10, pp. 2648–2659, 2007. View at: Publisher Site | Google Scholar
  8. A. Zonari, T. M. Martins, A. C. Paula et al., “Polyhydroxybutyrate-co-hydroxyvalerate structures loaded with adipose stem cells promote skin healing with reduced scarring,” Acta Biomaterialia, vol. 17, pp. 170–181, 2015. View at: Publisher Site | Google Scholar
  9. G. C. Gurtner, S. Werner, Y. Barrandon, and M. T. Longaker, “Wound repair and regeneration,” Nature, vol. 453, no. 7193, pp. 314–321, 2008. View at: Publisher Site | Google Scholar
  10. D. Wang, Z. Zhang, E. O’Loughlin et al., “MicroRNA-205 controls neonatal expansion of skin stem cells by modulating the PI(3)K pathway,” Nature Cell Biology, vol. 15, no. 10, pp. 1153–1163, 2013. View at: Publisher Site | Google Scholar
  11. J. Yu, H. Peng, Q. Ruan, A. Fatima, S. Getsios, and R. M. Lavker, “MicroRNA-205 promotes keratinocyte migration via the lipid phosphatase SHIP2,” FASEB Journal, vol. 24, no. 10, pp. 3950–3959, 2010. View at: Publisher Site | Google Scholar
  12. P. A. Zuk, M. Zhu, H. Mizuno et al., “Multilineage cells from human adipose tissue: implications for cell-based therapies,” Tissue Engineering, vol. 7, no. 2, pp. 211–228, 2001. View at: Publisher Site | Google Scholar
  13. T. M. Martins, A. C. de Paula, D. A. Gomes, and A. M. Goes, “Alkaline phosphatase expression/activity and multilineage differentiation potential are the differences between fibroblasts and orbital fat-derived stem cells – a study in animal serum-free culture conditions,” Stem Cell Reviews and Reports, vol. 10, no. 5, pp. 697–711, 2014. View at: Publisher Site | Google Scholar
  14. C. Théry, S. Amigorena, G. Raposo, and A. Clayton, “Isolation and characterization of exosomes from cell culture supernatants and biological fluids,” Current Protocols in Cell Biology, pp. 3.22.1–3.22.29, 2006. View at: Publisher Site | Google Scholar
  15. C. S. Melo, J. A. Arantes Faria, N. C. Corrêa et al., “Cytoplasmic-targeted parvalbumin blocks the proliferation of multipotent mesenchymal stromal cells in prophase,” Stem Cell Research & Therapy, vol. 4, no. 4, p. 92, 2013. View at: Publisher Site | Google Scholar
  16. X. Wang, J. Ge, E. E. Tredget, and Y. Wu, “The mouse excisional wound splinting model, including applications for stem cell transplantation,” Nature Protocols, vol. 8, no. 2, pp. 302–309, 2013. View at: Publisher Site | Google Scholar
  17. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at: Publisher Site | Google Scholar
  18. P. Bourin, B. A. Bunnell, L. Casteilla et al., “Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT),” Cytotherapy, vol. 15, no. 6, pp. 641–648, 2013. View at: Publisher Site | Google Scholar
  19. M. Yáñez-Mó, P. R. Siljander, Z. Andreu et al., “Biological properties of extracellular vesicles and their physiological functions,” Journal of Extracellular Vesicles, vol. 4, no. 1, article 27066, 2015. View at: Google Scholar
  20. S. L. Maas, X. O. Breakefield, and A. M. Weaver, “Extracellular vesicles: unique intercellular delivery vehicles,” Trends in Cell Biology, vol. 27, no. 3, pp. 172–188, 2017. View at: Publisher Site | Google Scholar
  21. I. Pastar, O. Stojadinovic, N. C. Yin et al., “Epithelialization in wound healing: a comprehensive review,” Advances in Wound Care, vol. 3, no. 7, pp. 445–464, 2014. View at: Publisher Site | Google Scholar
  22. A. Sawicka and C. Seiser, “Histone H3 phosphorylation – a versatile chromatin modification for different occasions,” Biochimie, vol. 94, no. 11, pp. 2193–2201, 2012. View at: Publisher Site | Google Scholar
  23. M. Khan, E. Nickoloff, T. Abramova et al., “Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction,” Circulation Research, vol. 117, no. 1, pp. 52–64, 2015. View at: Publisher Site | Google Scholar
  24. A. Shabbir, A. Cox, L. Rodriguez-Menocal, M. Salgado, and E. Van Badiavas, “Mesenchymal stem cell exosomes induce proliferation and migration of normal and chronic wound fibroblasts, and enhance angiogenesis in vitro,” Stem Cells and Development, vol. 24, no. 14, pp. 1635–1647, 2015. View at: Publisher Site | Google Scholar
  25. G. D. Hoke, C. Ramos, N. N. Hoke, M. C. Crossland, L. G. Shawler, and J. V. Boykin, “Atypical diabetic foot ulcer keratinocyte protein signaling correlates with impaired wound healing,” Journal of Diabetes Research, vol. 2016, Article ID 1586927, 10 pages, 2016. View at: Publisher Site | Google Scholar
  26. B. Zhang, M. Wang, A. Gong et al., “HucMSC-exosome mediated-Wnt4 signaling is required for cutaneous wound healing,” Stem Cells, vol. 33, no. 7, pp. 2158–2168, 2015. View at: Publisher Site | Google Scholar
  27. X. Li, L. Liu, J. Yang et al., “Exosome derived from human umbilical cord mesenchymal stem cell mediates miR-181c attenuating burn-induced excessive inflammation,” eBioMedicine, vol. 8, pp. 72–82, 2016. View at: Publisher Site | Google Scholar
  28. A. Y. Qin, X. W. Zhang, L. Liu et al., “MiR-205 in cancer: an angel or a devil?” European Journal of Cell Biology, vol. 92, no. 2, pp. 54–60, 2013. View at: Publisher Site | Google Scholar
  29. T. Wang, N. Zhao, S. Long et al., “Downregulation of miR-205 in migrating epithelial tongue facilitates skin wound re-epithelialization by derepressing ITGA5,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1862, no. 8, pp. 1443–1452, 2016. View at: Publisher Site | Google Scholar

Copyright © 2017 Andrea da Fonseca Ferreira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.